P01-45 Twenty-four months efficacy and safety of LB03002, a...

Growth Hormone & IGF Research 2012 / 10 Vol. 22

P01-45 Twenty-four months efficacy and safety of LB03002, a new sustained release formulation of rhGH, in children with GHD: Extension of a phase III randomized multicentre study

Saenger, P., Khadilkar, V., Radjuk, K.A., Bolshova, E., Khadgawat, R., El Kholy, M., Desai, M., Peterkova, V., Mericq, V., Ji, H.-J., Bae, Y.J., Lopez, P., Martin, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Growth Hormone & IGF Research
DOI:
10.1016/S1096-6374(12)60124-5
Date:
October, 2012
File:
PDF, 58 KB
english, 2012
Conversion to is in progress
Conversion to is failed